S.L. Primo-Parmo

2.5k total citations · 2 hit papers
19 papers, 2.1k citations indexed

About

S.L. Primo-Parmo is a scholar working on Pharmacology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, S.L. Primo-Parmo has authored 19 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Molecular Biology and 6 papers in Clinical Biochemistry. Recurrent topics in S.L. Primo-Parmo's work include Cholinesterase and Neurodegenerative Diseases (9 papers), Paraoxonase enzyme and polymorphisms (6 papers) and Computational Drug Discovery Methods (5 papers). S.L. Primo-Parmo is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (9 papers), Paraoxonase enzyme and polymorphisms (6 papers) and Computational Drug Discovery Methods (5 papers). S.L. Primo-Parmo collaborates with scholars based in United States, Brazil and Israel. S.L. Primo-Parmo's co-authors include Bert N. La Du, Michael Aviram, Robert C. Sorenson, Roger S. Newton, Mira Rosenblat, C L Bisgaier, John F. Teiber, Scott S. Billecke, Mohamad Navab and Theodore J. Standiford and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Anesthesiology.

In The Last Decade

S.L. Primo-Parmo

19 papers receiving 2.0k citations

Hit Papers

Paraoxonase inhibits high-density lipoprotein oxidation a... 1996 2026 2006 2016 1998 1996 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    1998 984 citations Michael Aviram, Mira Rosenblat et al. Journal of Clinical Investigation profile →
  2. The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene Family
    1996 538 citations S.L. Primo-Parmo, Robert C. Sorenson et al. Genomics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.L. Primo-Parmo United States 12 1.6k 813 644 446 291 19 2.1k
Robert C. Sorenson United States 10 1.8k 1.2× 947 1.2× 550 0.9× 565 1.3× 287 1.0× 11 2.1k
H W Eckerson United States 12 1.1k 0.7× 561 0.7× 519 0.8× 316 0.7× 325 1.1× 14 1.9k
Scott S. Billecke United States 20 1.8k 1.1× 927 1.1× 523 0.8× 605 1.4× 459 1.6× 30 2.6k
Saeed Mahmood Qatar 11 380 0.2× 363 0.4× 150 0.2× 119 0.3× 188 0.6× 25 1.0k
Hicham Berrougui Canada 26 382 0.2× 350 0.4× 180 0.3× 93 0.2× 362 1.2× 67 1.6k
S. Adkins United States 10 501 0.3× 378 0.5× 377 0.6× 159 0.4× 299 1.0× 19 1.0k
Hany M. El‐Bassossy Egypt 27 240 0.2× 214 0.3× 228 0.4× 130 0.3× 441 1.5× 78 1.7k
M.S. van der Gaag Netherlands 13 204 0.1× 288 0.4× 104 0.2× 136 0.3× 289 1.0× 20 1.4k
Palla Suryanarayana India 26 533 0.3× 164 0.2× 179 0.3× 44 0.1× 738 2.5× 40 2.0k
La Du Bn United States 8 353 0.2× 158 0.2× 99 0.2× 164 0.4× 205 0.7× 10 778

Countries citing papers authored by S.L. Primo-Parmo

Since Specialization
Citations

This map shows the geographic impact of S.L. Primo-Parmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.L. Primo-Parmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.L. Primo-Parmo more than expected).

Fields of papers citing papers by S.L. Primo-Parmo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.L. Primo-Parmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.L. Primo-Parmo. The network helps show where S.L. Primo-Parmo may publish in the future.

Co-authorship network of co-authors of S.L. Primo-Parmo

This figure shows the co-authorship network connecting the top 25 collaborators of S.L. Primo-Parmo. A scholar is included among the top collaborators of S.L. Primo-Parmo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.L. Primo-Parmo. S.L. Primo-Parmo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Du, Bert N. La, Michael Aviram, Scott S. Billecke, et al.. (1999). On the physiological role(s) of the paraoxonases. Chemico-Biological Interactions. 119-120. 379–388. 157 indexed citations
2.
Billecke, Scott S., et al.. (1999). Characterization of a soluble mouse liver enzyme capable of hydrolyzing diisopropyl phosphorofluoridate. Chemico-Biological Interactions. 119-120. 251–256. 30 indexed citations
3.
Aviram, Michael, Mira Rosenblat, C L Bisgaier, et al.. (1998). Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.. Journal of Clinical Investigation. 101(8). 1581–1590. 984 indexed citations breakdown →
4.
Primo-Parmo, S.L., H. Lightstone, & Bert N. La Du. (1997). Characterization of an unstable variant (BChE115D) of human butyrylcholinesterase. Pharmacogenetics. 7(1). 27–34. 15 indexed citations
5.
Primo-Parmo, S.L., Robert C. Sorenson, John F. Teiber, & Bert N. La Du. (1996). The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene Family. Genomics. 33(3). 498–507. 538 indexed citations breakdown →
6.
Primo-Parmo, S.L., et al.. (1996). Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.. PubMed. 58(1). 52–64. 85 indexed citations
7.
Greenberg, Carolyn, S.L. Primo-Parmo, Eugene J. Pantuck, & Bert N. La Du. (1995). Prolonged Response to Succinylcholine. Anesthesia & Analgesia. 81(2). 419–421. 13 indexed citations
8.
Sorenson, Robert C., S.L. Primo-Parmo, Sally A. Camper, & Bert N. La Du. (1995). The Genetic Mapping and Gene Structure of Mouse Paraoxonase/Arylesterase. Genomics. 30(3). 431–438. 35 indexed citations
9.
Sorenson, Robert C., S.L. Primo-Parmo, Chien-Hung Kuo, et al.. (1995). Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase.. Proceedings of the National Academy of Sciences. 92(16). 7187–7191. 116 indexed citations
10.
Greenberg, Carolyn, S.L. Primo-Parmo, Eugene J. Pantuck, & Bert N. La Du. (1995). Prolonged Response to Succinylcholine. Anesthesia & Analgesia. 81(2). 419–421. 4 indexed citations
11.
Picheth, Geraldo, et al.. (1994). An improved method for butyrylcholinesterase phenotyping. Biochemical Genetics. 32(3-4). 83–89. 6 indexed citations
12.
Primo-Parmo, S.L., Carolyn Greenberg, Eugene J. Pantuck, & Bert N. La Du. (1994). A NEW VARIANT OF HUMAN BUTYRYLCHOLINESTERASE WITH REDUCED AFFINITY FOR SUCCINYLCHOLINE. Anesthesiology. 81(SUPPLEMENT). A461–A461. 3 indexed citations
13.
Hidaka, Kazuo, et al.. (1992). [Identification of two different genetic mutation associated with silent phenotypes for human serum cholinesterase in Japanese].. PubMed. 40(5). 535–40. 11 indexed citations
14.
Chautard‐Freire‐Maia, Eleidi A., et al.. (1991). The C<sub>5</sub> Isozyme of Serum Cholinesterase and Adult Weight. Human Heredity. 41(5). 330–339. 30 indexed citations
15.
Chautard‐Freire‐Maia, Eleidi A., et al.. (1984). Frequencies of Atypical Serum Cholinesterase among Caucasians and Negroes from Southern Brazil. Human Heredity. 34(6). 388–392. 3 indexed citations
16.
Primo-Parmo, S.L. & Eleidi A. Chautard‐Freire‐Maia. (1982). Absence of linkage between the serum cholinesterase (CHE1) and rhesus (RH) loci. Human Genetics. 60(3). 284–286. 3 indexed citations
17.
18.
Chautard‐Freire‐Maia, Eleidi A., S.L. Primo-Parmo, Marta Pinheiro, & N. Freire‐Maia. (1981). Further evidence against linkage between christ-siemens-touraine (CST) and XG loci. Human Genetics. 57(2). 205–6. 2 indexed citations
19.
Primo-Parmo, S.L., et al.. (1979). Frequencies of hemoglobin S in Curitiba. Ciencia e cultura. 31(11). 1275–1277. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert C. Sorenson Breakdown of academic impact, for papers by H W Eckerson Breakdown of academic impact, for papers by Scott S. Billecke Breakdown of academic impact, for papers by Saeed Mahmood Breakdown of academic impact, for papers by Hicham Berrougui Breakdown of academic impact, for papers by S. Adkins Breakdown of academic impact, for papers by Hany M. El‐Bassossy Breakdown of academic impact, for papers by M.S. van der Gaag Breakdown of academic impact, for papers by Palla Suryanarayana Breakdown of academic impact, for papers by La Du Bn
Rankless by CCL
2026